Vice President of Sales

Suvoda sets new standard for streamlined patient and site experience in clinical trials. CONSHOHOCKEN, Pa., Jan. 12, 2026 /PRNewswire/ - Suvoda, a clinical trial technology company, took decisive steps in 2025 toward a more connected and streamlined clinical trial experience for both patients and sites. The company's merger with Greenphire marked a pivotal moment in that journey, strengthening Suvoda's ability to tackle persistent trial operational challenges with a more unified approach. Together with continued product innovation and deployment of AI tools, Suvoda closed the year with growing momentum toward a single, cohesive ecosystem that reduces complexity across the clinical trial lifecycle. "The last twelve months marked an important step forward for Suvoda," said Jagath Wanninayake, CEO of Suvoda. "Our teams worked with care and intention as we brought two strong companies together and delivered new capabilities that reflect what patients and sites actually need. As we enter 2026, we're focused on helping sponsors and sites navigate their trials with clarity while giving patients a smoother, more supportive experience." Making the patient journey easier A defining milestone of the year was the launch of Suvoda's patient app, a clear demonstration of how a unified platform can meaningfully improve the clinical trial experience for patients. The app brings eCOA questionnaires, patient payments, reminders, and visit scheduling into one consumer-grade interface that patients can use on their own devices. This advancement helps participants stay engaged while easing the administrative load for busy sites. Harnessing AI to alleviate administrative burden in clinical trials Suvoda also simplified how study teams access critical information with Sofia, an AI assistant currently deployed in Suvoda IRT with platform expansion in the future. Sofia helps users ask questions and get answers with a generative AI tool, replacing multi-step navigation with quick, clear responses. Built with strong privacy and role-based controls, Sofia supports everyday decision making for study teams without compromising data security or the integrity of the study blind. Suvoda's approach earned continued recognition in 2025, including a new patent for its platform architecture, bringing its total to five. Everest Group also named Suvoda a Leader in its RTSM PEAK Matrix(R) assessment. Across its portfolio, Suvoda released enhancements that improve transparency, data quality, and ease of use, reflecting its ongoing focus on practical innovation that supports real-world trial operations. The company anticipates continuing its strong growth in 2026 as pharmaceutical sponsors and CROs increasingly look for unified platforms that reduce trial complexity while supporting exceptional patient and site experiences. "We spent 2025 not only merging two companies, but unifying our technologies, our people, and our mission," Wanninayake said. "That foundation positions us to deliver even greater value in 2026 and beyond. We're ready to support sponsors and sites to meet more of their clinical trial needs and help patients move through their studies with ease and confidence." About Suvoda Suvoda is a global clinical trial technology company with a market-leading, real-time software platform that empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 2000 trials across more than 95 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. To learn more, visit suvoda.com and follow Suvoda on LinkedIn. Logo - https://mma.prnasia.com/media2/1759317/Suvoda_updated_Logo.jpg?p=medium600 The information provided in this article was created by Cision PR Newswire, its news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of Siam News Network.

Suvoda launches a unified application for patients to reduce logistical challenges for clinical trial participants. CONSHOHOCKEN, Pa., October 29, 2025 /PRNewswire/ - Suvoda (recently merged under common ownership with Greenphire), a global clinical trial technology company specializing in software solutions to address the complexity of trials in critical and urgent times, today announced the launch of its unified mobile application for patients. The Suvoda app offers a unique and intuitive experience that integrates visit scheduling, questionnaires, travel information, receipt submission, and reimbursement tracking in one place to reduce the logistical burden on clinical trial participants. The new patient application combines four main product capabilities into a consumer-level interface so participants can: * Complete questionnaires and diaries * Schedule and reschedule study visits with real-time calendar availability * View travel details and itineraries (coming early 2026) * Submit receipts and track the status of reimbursements * Receive automatic reminders that help keep trials on track "The Suvoda app is different from any other participant application on the market today. It offers a unique combination of support tools that patients need. Knowing that patient dropout is a key risk for any clinical trial, our industry must do everything possible to support participants and keep them enrolled in their study," said Jagath Wanninayake, CEO of Suvoda. In a recently published global survey of clinical trial participants, conducted by the Center for Information and Study on Clinical Research Participation (CISCRP), researchers found that 63% of clinical trial participants stated that a smartphone application for data collection is a very useful service (CISCRP 2025 Perceptions and Information Study). Elizabeth Morris, Director of Product Management at Suvoda, agrees with these findings. "Patients constantly tell us that logistics is one of the biggest burdens of participating in a clinical trial. When people have to switch between emails, phone calls, and multiple systems, it adds time and stress. Unifying everything for patients reduces that friction and allows them to complete important tasks in one place." For patients, the application offers simple and secure login and a dashboard with assigned tasks. Clinical trial centers will be able to create automatic notifications to remind patients of their upcoming visits, take their medication, or complete questionnaires. Study teams can review and approve reimbursements in the same unified ecosystem, keeping center and participant views synchronized. With these innovations, the application facilitates the tasks of study center teams and eases compliance with the trial protocol. Following Suvoda's merger with Greenphire earlier this year, the combined organization integrates IRT, eCOA, and eConsent functions, along with payment, travel, and budget functions, all on the Suvoda platform, creating a comprehensive and integrated toolset to support the full patient experience in clinical trials. The patient application is an example of this unified experience and is already available. Additional improvements are planned for early 2026, including the incorporation of Greenphire Travel functions into the patient application and a unified login on the Suvoda platform for centers and sponsors. About Suvoda Suvoda is a global clinical trial technology company with a real-time experience platform that enables sponsors and CROs to make decisions with confidence, and centers and patients to act with calm and control. Suvoda offers interconnected, action-oriented software solutions, as well as industry-leading services and support, so that even in the most urgent and critical moments, life-changing studies keep moving forward. Headquartered in the suburbs of Philadelphia, Suvoda also has offices in Portland, Oregon; Barcelona, Spain; Bucharest and Iasi, Romania; and Tokyo, Japan. The company maintains customer satisfaction rates that consistently exceed the technology industry average, which has contributed to the company being selected by clinical trial sponsors and CROs to support over 2,000 trials in more than 95 countries. Suvoda recently merged with Greenphire, a leading provider of financial management tools and patient support for clinical trials. For more information, visit suvoda.com. Follow Suvoda on LinkedIn.